Clinical Trial Update: A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study comparing PF-06835919 in participants with hepatic impairment and healthy participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• PF-06835919

Snippet

Sponsor: Pfizer | Conditions: Hepatic Impairment, Healthy Participants | Phase 1 | Status: COMPLETED | Results posted: 2024-02-16